Medicare Enrolled

Dr. Daniel Lebovic, M.D.

Medical Oncology · Grosse Pointe Woods, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
19229 MACK AVE, Grosse Pointe Woods, MI 48236
3138845522
In practice since 2007 (19 years)
NPI: 1740302850 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lebovic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lebovic? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lebovic

Dr. Daniel Lebovic is a medical oncology specialist in Grosse Pointe Woods, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lebovic performed 500 Medicare services across 278 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lebovic received a total of $394,597 from 39 pharmaceutical and/or device companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lebovic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 49% volume in MI $394,597 industry payments

Medicare Practice Summary

Medicare Utilization ↗
500
Medicare services
Top 49% in MI for medical oncology
278
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
168 $73 $125
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
87 $66 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
82 $47 $87
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
57 $141 $288
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
53 $99 $135
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
20 $26 $58
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
19 $49 $96
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $99 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$394,597
Total received (2018-2024)
Avg $56,371/year across 7 years
Top 3% in MI for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
345
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$392,149 (99.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,885 (0.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$562 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$23,936
2023
$42,671
2022
$55,912
2021
$62,088
2020
$47,291
2019
$98,314
2018
$64,385

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$8,324
Genentech USA, Inc.
$5,815
ABBVIE INC.
$4,750
Amgen Inc.
$3,300
PharmaEssentia USA Corporation
$1,540
Janssen Biotech, Inc.
$87
Merck Sharp & Dohme LLC
$33
Eisai Inc.
$26
GlaxoSmithKline, LLC.
$21
SOBI, INC
$21
Genmab U.S., Inc.
$19
Top 3 companies account for 78.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$101,252
GENZYME CORPORATION
$83,845
Takeda Pharmaceuticals U.S.A., Inc.
$73,922
Celgene Corporation
$73,386
Genentech USA, Inc.
$20,451
ABBVIE INC.
$14,726
AbbVie, Inc.
$10,272
AbbVie Inc.
$6,608
Epizyme, Inc.,
$6,250
PharmaEssentia USA Corporation
$1,540
TG THERAPEUTICS, INC.
$562
Janssen Biotech, Inc.
$340
AstraZeneca Pharmaceuticals LP
$146
Adaptive Biotechnologies Corporation
$137
GlaxoSmithKline, LLC.
$133
Alexion Pharmaceuticals, Inc.
$130
Biogen, Inc.
$101
Janssen Scientific Affairs, LLC
$97
E.R. Squibb & Sons, L.L.C.
$93
Novartis Pharmaceuticals Corporation
$85
Pharmacyclics LLC, An AbbVie Company
$77
Eisai Inc.
$43
Jazz Pharmaceuticals Inc.
$40
PFIZER INC.
$36
JAZZ PHARMACEUTICALS INC.
$33
Merck Sharp & Dohme LLC
$33
Janssen Pharmaceuticals, Inc
$31
Exelixis Inc.
$29
Kyowa Kirin, Inc.
$26
Merck Sharp & Dohme Corporation
$26
Gilead Sciences, Inc.
$24
SOBI, INC
$21
EISAI INC.
$20
Genmab U.S., Inc.
$19
Astellas Pharma US Inc
$14
Spectrum Pharmaceuticals Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Incyte Corporation
$12
EMD Serono, Inc.
$8
Top 3 companies account for 65.6% of all-time payments
Associated products mentioned in payments ›
AFINITOR · Abraxane · BESREMI · Bavencio · Blincyto · CABLIVI · CALQUENCE · CEREZYME · Cabometyx · DARZALEX · ELITEK · EMPLICITI · Epkinly · Erleada · FASLODEX · Folotyn · GAUCHER-DISEASE · Halaven · IMBRUVICA · IMFINZI · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · Kyprolis · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MYLOTARG · NINLARO · Nplate · OPDIVO · POTELIGEO · PROMACTA · Polivy · Pomalyst · REBLOZYL · Revlimid · SARCLISA · SOLIRIS · SUTENT · TAGRISSO · TAZVERIK · TECVAYLI · TUMOR LYSIS SYNDROME - DISEASE · UKONIQ · VENCLEXTA · VONJO · VYXEOS · Venclexta · XARELTO · XGEVA · XTANDI · Xospata · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for medical oncology in MI.

Looking for a medical oncology specialist in Grosse Pointe Woods?
Compare medical oncologists in the Grosse Pointe Woods area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
31
Per 100K population
1.7
County median income
$59,521
Nearest hospital
HENRY FORD HEALTH ST JOHN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lebovic is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lebovic experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lebovic performed 168 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lebovic receive payments from pharmaceutical companies?
Yes. Dr. Lebovic received a total of $394,597 from 39 companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lebovic's costs compare to other medical oncologists in Grosse Pointe Woods?
Dr. Lebovic's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lebovic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →